Atorvastatin Calcium

Catalog No.S2077 Batch:S207752

Print

Technical Data

Formula

2(C33H34FN2O5).Ca
Molecular Weight 1155.34 CAS No. 134523-03-8
Solubility (25°C)* In vitro DMSO 100 mg/mL (86.55 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
2%DMSO 35%PEG300 2%Tween80 61%ddH2O
4.0mg/ml Taking the 1 mL working solution as an example, add 20 μL of 200 mg/ml clarified DMSO stock solution to 350 μL PEG300, mix evenly to clarify it; add 20 μL Tween80 to the above system, mix evenly to clarify it; then continue to add 610 μL ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Atorvastatin Calcium is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol. Atorvastatin Calcium induces apoptosis and autophagy.
Targets
HMG-CoA reductase [1]
(Cell-free assay)
In vitro

Atorvastatin inhibits pre-proET-1 mRNA expression in a concentration- and time-dependent fashion (60-70% maximum inhibition) and reduces immunoreactive ET-1 levels (25-50%), this inhibitory effect is maintained in the presence of oxidized LDL (1-50 mg/mL). [1]

Atorvastatin significantly reduces angiotensin II-induced and epidermal growth factor-induced ROS production in VSMCs. Atorvastatin downregulates mRNA expression of the NAD(P)H oxidase subunit nox1 in VSMCs, whereas p22phox mRNA expression is not significantly altered. Atorvastatin inhibits membrane translocation of rac1 GTPase, which is required for the activation of NAD(P)H oxidase. [2]

Atorvastatin (0.1 μM) significantly diminishes NF-κB activation induced by Ang II and TNF-α in mononuclear cells and VSMC. Atorvastatin (1 μM) diminishes MCP-1 expression induced by Ang II, TNF-α and is reversed by Mevalonate only in Ang II-stimulated cells. Atorvastatin (1 μM) diminishes IP-10 expression induced by Ang II and by TNF-α in VSMC, and this reduction is partially reversed by Mevalonate. [3]

Atorvastatin and Gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. [4]
In vivo

Atorvastatin reduces vascular mRNA expression of p22phox and nox1 and increased aortic catalase expression in statin-treated rats. [2]

Atorvastatin inhibits the increase of hsCRP serum levels in the cholesterol-fed rabbits. Atorvastatin inhibits the increase in osteopontin expression throughout the valve leaflet in the hypercholesterolemic aortic valves. [5]

Protocol (from reference)

Cell Assay:

[1]
  • Cell lines

    BAECs

  • Concentrations

    10 μM

  • Incubation Time

    24 h

  • Method

    Cells were treated with indicated concentration of the drug for 24 hour.
Animal Study:

[5]
  • Animal Models

    Male New Zealand White rabbits

  • Dosages

    3 mg/kg

  • Administration

    p.o.

Customer Product Validation

Data from [BMC Pharmacol Toxicol, 2013, 14, 15]

Selleck's Atorvastatin Calcium has been cited by 10 publications

Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins [ Cancers (Basel), 2022, 14(9)2327] PubMed: 35565457
Ultra-fast proteomics with Scanning SWATH [ Nat Biotechnol, 2021, 10.1038/s41587-021-00860-4] PubMed: 33767396
The thrombin receptor links brain derived neurotrophic factor to neuron cholesterol production, resiliency and repair after spinal cord injury [ Neurobiol Dis, 2021, 152:105294] PubMed: 33549720
Atorvastatin potentiates the chemosensitivity of human liver cancer cells to cisplatin via downregulating YAP1 [ Oncol Lett, 2021, 21(2):82] PubMed: 33363619
The MEK5-ERK5 kinase axis controls lipid metabolism in small cell lung cancer. [ Cancer Res, 2020, canres.1027.2019] PubMed: 31969375
Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway [ Stem Cell Res Ther, 2020, 11(1):350] PubMed: 32787917
A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition. [ Nat Commun, 2019, 10(1):96] PubMed: 30626880
Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus [ J Virol, 2017, 91(16)e00461-17] PubMed: 28566376
Lovastatin induces apoptosis of HepG-2 cells by activating ROS-dependent mitochondrial and ER stress pathways [ Int J Clin Exp Pathol, 2017, 10(12):11480-11488] PubMed: 31966503
Bioenergetic study of murine hepatic tissue treated in vitro with atorvastatin. [Alfazari AS, et al. BMC Pharmacol Toxicol, 2013, 14:15] PubMed: 23448291

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.